Trials / Unknown
UnknownNCT05009186
Changing of Prostate Specific Antigen Value in Patients With Covid-19
Changing of PSA With Covid-19
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Saglik Bilimleri Universitesi · Academic / Other
- Sex
- Male
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.
Detailed description
Patients with positive PCR test results were included in the study. The age of the patient and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both at the time the patients applied and three weeks after the patient recovered. PSA and free PSA were also measured in the same way. Patients whose symptoms improved and the PCR test result was negative were considered as recovered.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PSA value | We measure PSA value during and after covid-19 infection |
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2021-10-01
- Completion
- 2021-10-01
- First posted
- 2021-08-17
- Last updated
- 2021-08-17
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05009186. Inclusion in this directory is not an endorsement.